Cellular HIV-1 restriction factors: a new avenue for AIDS therapy?

Tetherin: Holding On and Letting Go

(2010) Daniel Sauter et al.   CELL

Structural Basis of HIV-1 Tethering to Membranes by the BST-2/Tetherin Ectodomain

(2010) Andreas Hinz et al.   Cell Host & Microbe

Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics

(2010) John S. Albin et al.   EXPERT REVIEWS IN MOLECULAR MEDICINE

Cloning, eukaryotic expression of human ISG20 and preliminary study on the effect of its anti-HBV

(2010) Youhua Hao et al.   Journal of Huazhong University of Science and Technology-Medical Sciences

The Interferon-Induced Gene ISG15 Blocks Retrovirus Release from Cells Late in the Budding Process

(2010) A. Pincetic et al.   JOURNAL OF VIROLOGY

APOBEC3F and APOBEC3G Inhibit HIV-1 DNA Integration by Different Mechanisms

(2010) J. L. Mbisa et al.   JOURNAL OF VIROLOGY

Susceptibility of xenotropic murine leukemia virus-related virus (XMRV) to retroviral restriction factors

(2010) H. C. T. Groom et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

ISG15 conjugation system targets the viral NS1 protein in influenza A virus-infected cells

(2010) C. Zhao et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

TRIM5α Modulates Immunodeficiency Virus Control in Rhesus Monkeys

(2010) So-Yon Lim et al.   PLoS Pathogens

ISG15 over-expression inhibits replication of the Japanese encephalitis virus in human medulloblastoma cells

(2009) Nai-Wan Hsiao et al.   ANTIVIRAL RESEARCH

Tetherin Inhibits HIV-1 Release by Directly Tethering Virions to Cells

(2009) David Perez-Caballero et al.   CELL

Nef Proteins from Simian Immunodeficiency Viruses Are Tetherin Antagonists

(2009) Fengwen Zhang et al.   Cell Host & Microbe

HIV-1 Antagonism of CD317 Is Species Specific and Involves Vpu-Mediated Proteasomal Degradation of the Restriction Factor

(2009) Christine Goffinet et al.   Cell Host & Microbe

The human IFN-inducible p53 target gene TRIM22 colocalizes with the centrosome independently of cell cycle phase

(2009) Jessica Petersson et al.   EXPERIMENTAL CELL RESEARCH

HIV-1 assembly at the plasma membrane: Gag trafficking and localization

(2009) Akira Ono   Future Virology

Leveraging APOBEC3 proteins to alter the HIV mutation rate and combat AIDS

(2009) Judd F Hultquist et al.   Future Virology

Tripartite motif-containing 22 inhibits the activity of hepatitis B virus core promoter, which is dependent on nuclear-located RING domain

(2009) Bo Gao et al.   HEPATOLOGY

Rubella vaccine-induced cellular immunity: evidence of associations with polymorphisms in the Toll-like, vitamin A and D receptors, and innate immune response genes

(2009) Inna G. Ovsyannikova et al.   HUMAN GENETICS

Determinants for the Rhesus Monkey TRIM5α-mediated Block of the Late Phase of HIV-1 Replication

(2009) Ryuta Sakuma et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

TRIM22 E3 ubiquitin ligase activity is required to mediate antiviral activity against encephalomyocarditis virus

(2009) P. Eldin et al.   JOURNAL OF GENERAL VIROLOGY

APOBEC3BDeletion and Risk of HIV‐1 Acquisition

(2009) Ping An et al.   JOURNAL OF INFECTIOUS DISEASES

Polymorphisms in the Vitamin A Receptor and Innate Immunity Genes Influence the Antibody Response to Rubella Vaccination

(2009) Inna G. Ovsyannikova et al.   JOURNAL OF INFECTIOUS DISEASES

RNA Dimerization Promotes PKR Dimerization and Activation

(2009) Laurie A. Heinicke et al.   JOURNAL OF MOLECULAR BIOLOGY

Interferon-Induced ISG15 Conjugation Inhibits Influenza A Virus Gene Expression and Replication in Human Cells

(2009) T.-Y. Hsiang et al.   JOURNAL OF VIROLOGY

Analysis of the Percentage of Human Immunodeficiency Virus Type 1 Sequences That Are Hypermutated and Markers of Disease Progression in a Longitudinal Cohort, Including One Individual with a Partially Defective Vif

(2009) A. Piantadosi et al.   JOURNAL OF VIROLOGY

Regulation of Porcine Endogenous Retrovirus Release by Porcine and Human Tetherins

(2009) G. Mattiuzzo et al.   JOURNAL OF VIROLOGY

Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand

(2009) Supachai Rerks-Ngarm et al.   NEW ENGLAND JOURNAL OF MEDICINE

Vpu enhances HIV-1 virus release in the absence of Bst-2 cell surface down-modulation and intracellular depletion

(2009) Eri Miyagi et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

APOBEC3G mRNA expression in exposed seronegative and early stage HIV infected individuals decreases with removal of exposure and with disease progression

(2009) Joel A Vazquez-Perez et al.   Retrovirology

Comparative study on the effect of human BST-2/Tetherin on HIV-1 release in cells of various species

(2009) Kei Sato et al.   Retrovirology

Genetic Variation in OAS1 Is a Risk Factor for Initial Infection with West Nile Virus in Man

(2009) Jean K. Lim et al.   PLoS Pathogens

HIV-1 Vpu Neutralizes the Antiviral Factor Tetherin/BST-2 by Binding It and Directing Its Beta-TrCP2-Dependent Degradation

(2009) Bastien Mangeat et al.   PLoS Pathogens

An Antiviral Response Directed by PKR Phosphorylation of the RNA Helicase A

(2009) Anthony J. Sadler et al.   PLoS Pathogens

The Level of APOBEC3G (hA3G)-Related G-to-A Mutations Does Not Correlate with Viral Load in HIV Type 1-Infected Individuals

(2008) Nzovu K. Ulenga et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

The Interferon-Induced Protein BST-2 Restricts HIV-1 Release and Is Downregulated from the Cell Surface by the Viral Vpu Protein

(2008) Nanette Van Damme et al.   Cell Host & Microbe

Safety and Immunogenicity of a Replication‐Incompetent Adenovirus Type 5 HIV‐1 Clade Bgag/pol/nefVaccine in Healthy Adults

(2008) Frances H. Priddy et al.   CLINICAL INFECTIOUS DISEASES

The structural biology of HIV assembly

(2008) Barbie K Ganser-Pornillos et al.   CURRENT OPINION IN STRUCTURAL BIOLOGY

ISG15 Inhibits Nedd4 Ubiquitin E3 Activity and Enhances the Innate Antiviral Response

(2008) Oxana A. Malakhova et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

ISG15 Arg151 and the ISG15-Conjugating Enzyme UbE1L Are Important for Innate Immune Control of Sindbis Virus

(2008) N. V. Giannakopoulos et al.   JOURNAL OF VIROLOGY

Human Immunodeficiency Virus (HIV) Type 1 Proviral Hypermutation Correlates with CD4 Count in HIV-Infected Women from Kenya

(2008) A. M. Land et al.   JOURNAL OF VIROLOGY

Polymorphisms and Splice Variants Influence the Antiretroviral Activity of Human APOBEC3H

(2008) A. Harari et al.   JOURNAL OF VIROLOGY

The DNA Deaminase Activity of Human APOBEC3G Is Required for Ty1, MusD, and Human Immunodeficiency Virus Type 1 Restriction

(2008) A. J. Schumacher et al.   JOURNAL OF VIROLOGY

HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysis

(2008) M Juliana McElrath et al.   LANCET

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial

(2008) Susan P Buchbinder et al.   LANCET

Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu

(2008) Stuart J. D. Neil et al.   NATURE

Small-molecule inhibition of HIV-1 Vif

(2008) Robin Nathans et al.   NATURE BIOTECHNOLOGY

HIV-1 envelope protein binds to and signals through integrin α4β7, the gut mucosal homing receptor for peripheral T cells

(2008) James Arthos et al.   NATURE IMMUNOLOGY

No effect of endogenous TRIM5α on HIV-1 production

(2008) Fengwen Zhang et al.   NATURE MEDICINE

The Effect of Trim5 Polymorphisms on the Clinical Course of HIV-1 Infection

(2008) Daniëlle van Manen et al.   PLoS Pathogens

ISG15 inhibits Ebola VP40 VLP budding in an L-domain-dependent manner by blocking Nedd4 ligase activity

(2008) A. Okumura et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

APOBEC3G-UBA2 fusion as a potential strategy for stable expression of APOBEC3G and inhibition of HIV-1 replication

(2008) Lin Li et al.   Retrovirology

Single-stranded RNA facilitates nucleocapsid: APOBEC3G complex formation

(2008) H. P. Bogerd et al.   RNA

Vaccinia Virus E3 Protein Prevents the Antiviral Action of ISG15

(2008) Susana Guerra et al.   PLoS Pathogens

The Interferon Response Inhibits HIV Particle Production by Induction of TRIM22

(2008) Stephen D. Barr et al.   PLoS Pathogens

HIV-1 Vif promotes the formation of high molecular mass APOBEC3G complexes

(2007) Ritu Goila-Gaur et al.   VIROLOGY

HIV-1 accessory proteins VPR and Vif modulate antiviral response by targeting IRF-3 for degradation

(2007) Atsushi Okumura et al.   VIROLOGY